Akers Biosciences (AKER) Signs Three Agreement with GNYHA to Introduce Heparin PF4 Rapid Test
Tweet Send to a Friend
Akers Biosciences, Inc. (NASDAQ: AKER) signed a three-year agreement with the Greater New York Hospital Association (GNYHA) to introduce the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
